Novonix Limited
NVNXF
$0.20
-$0.04-16.91%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.62M | 5.77M | 5.93M | 5.89M | 5.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.62M | 5.77M | 5.93M | 5.89M | 5.85M |
| Cost of Revenue | 2.50M | 1.95M | 1.41M | 1.59M | 1.77M |
| Gross Profit | 3.12M | 3.82M | 4.52M | 4.30M | 4.08M |
| SG&A Expenses | 45.09M | 45.55M | 46.01M | 47.54M | 49.08M |
| Depreciation & Amortization | 4.57M | 4.58M | 4.60M | 4.58M | 4.57M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.84M | 57.35M | 56.87M | 58.57M | 60.27M |
| Operating Income | -52.22M | -51.58M | -50.93M | -52.67M | -54.41M |
| Income Before Tax | -92.70M | -79.42M | -66.15M | -70.44M | -74.72M |
| Income Tax Expenses | 25.60K | 61.60K | 97.60K | 97.60K | 97.60K |
| Earnings from Continuing Operations | -92.73 | -79.49 | -66.25 | -70.53 | -74.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -92.73M | -79.49M | -66.25M | -70.53M | -74.82M |
| EBIT | -52.22M | -51.58M | -50.93M | -52.67M | -54.41M |
| EBITDA | -48.32M | -47.64M | -46.95M | -48.71M | -50.46M |
| EPS Basic | -0.13 | -0.13 | -0.12 | -0.14 | -0.15 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.06 | -0.07 | -0.07 |
| EPS Diluted | -0.14 | -0.13 | -0.12 | -0.14 | -0.15 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.06 | -0.07 | -0.07 |
| Average Basic Shares Outstanding | 2.73B | 2.50B | 2.27B | 2.13B | 1.99B |
| Average Diluted Shares Outstanding | 2.73B | 2.50B | 2.27B | 2.13B | 1.99B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |